In human Alzheimer’s disease though, it is the tau burden, not amyloid-β load, that predicts both brain atrophy as well as cognitive status in patients with Alzheimer’s disease (Giannakopoulos et al., 2003). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.